Categories
CBD In The News

5 Big Questions for 1 of the Hottest Marijuana Stocks on the Market

Its cannabinoid program includes a cannabidiol (CBD) oral solution and Syndros. Insys is evaluating the CBD product in treating epilepsy, infantile spasms, and genetic disorder Prader Willi syndrome. The company's sprays in development include buprenorphine, naloxone, and epinephrine.